Recerca / Convocatòries Projectes de recerca

ERA-NET ON TRANSLATIONAL CANCER RESEARCH (TRANSCAN-2) –“Translational research on rare cancers””


Convocatòria tancada
Entitat convocant:
European Commission
Àmbit:
Internacional
Inici:
Termini intern:
Termini real:
Descripció:

Objectiu de la convocatòria


TRANSCAN-2 has the goal of coordinating national and regional funding programmes for research in the area of translational cancer research. The specific challenge is to promote a transnational collaborative approach between scientific teams in demanding areas of translational cancer research while avoiding the duplication of efforts and ensuring a more efficient use of available resources, to produce significant results of higher quality and impact, and share data and infrastructures.
The EC co-funded call of TRANSCAN-2 (JTC 2017) will focus on: "Translational research on rare cancers".

 

Característiques principals


The proposals of the present call will have to cover a minimum of one of the specific aims reported below:

 

  • Aim 1: Design and conduct of translational research studies exploiting/combining resources from current clinical trials, bio-repositories and epidemiology-type resources.
  • Aim 2: Development and exploitation of translational research platforms (e.g., patient derived xenograft models/organoids/tissue collections) to study drug responses/resistance and toxicity, and perform drug screens or repurpose approved anticancer drugs.
  • Aim 3: Implementation of precision biomarkers for better stratification of the clinical cohorts.

    •  


    Requisits


    Only transnational projects will be funded. Each research consortium must involve a minimum of three (3) research groups and a maximum of seven (7) research groups. The groups must be from at least three (3) different countries participating in the call. In addition, a consortium must not involve more than two (2) research groups from one country (in such cases the minimum number of groups must be 4, coming from 3 different countries). The maximum number of 7 research groups could be increased only with partners from the following countries : Estonia, Latvia, Slovakia and Turkey, up to a maximum of 4 additional partners from the 4 countries, to reach a maximum total of 11 research groups in a proposal.

    In order to strengthen the European translational cancer research area, a wide inclusion of research teams from all the countries/regions participating in the call is encouraged, with a particular attention to research teams from Estonia, Latvia, Slovakia and Turkey.

    Each consortium must involve at least one basic or pre-clinical research team and one clinical team.

    Plase check the Call Text for detailed eligibility rules.

    For Spanish applicants: please check the eligibility requirements of the institution and the principal investigator/team members, in pages 56-59 of the Call Text.

    Dotació


    For Spanish participants:

     

  • up to 150,000 € (overheads included) per partner
  • up to 200.000 € (overheads included) per coordinator

    •  

     

    Durada

    3 years

     

    Convocatòria (URL)
    http://www.transcanfp7.eu/index.php/calls/fourth-joint-transnational-call-jtc-2017.html